APA

Wais V., Kündgen L., Bohl S. R., von Harsdorf S., Schlenk R. F., Döhner K., Teleanu V., Bullinger L., Nguyen T. M., Drognitz K., Moulin J., Binnenhei M., Bentz M., Döhner H., Bunjes D., Kuchenbauer F. & Ringhoffer M. (20190308). Reduced-toxicity conditioning for allogeneic hematopoietic cell transplantation in elderly or comorbid patients with AML using fludarabine, BCNU and melphalan: disease stage at transplant determines outcome. : Bone marrow transplantation.

Chicago

Wais V, Kündgen L, Bohl S R, von Harsdorf S, Schlenk R F, Döhner K, Teleanu V, Bullinger L, Nguyen T M, Drognitz K, Moulin J-C, Binnenhei M, Bentz M, Döhner H, Bunjes D, Kuchenbauer F and Ringhoffer M. 20190308. Reduced-toxicity conditioning for allogeneic hematopoietic cell transplantation in elderly or comorbid patients with AML using fludarabine, BCNU and melphalan: disease stage at transplant determines outcome. : Bone marrow transplantation.

Harvard

Wais V., Kündgen L., Bohl S. R., von Harsdorf S., Schlenk R. F., Döhner K., Teleanu V., Bullinger L., Nguyen T. M., Drognitz K., Moulin J., Binnenhei M., Bentz M., Döhner H., Bunjes D., Kuchenbauer F. and Ringhoffer M. (20190308). Reduced-toxicity conditioning for allogeneic hematopoietic cell transplantation in elderly or comorbid patients with AML using fludarabine, BCNU and melphalan: disease stage at transplant determines outcome. : Bone marrow transplantation.

MLA

Wais V, Kündgen L, Bohl S R, von Harsdorf S, Schlenk R F, Döhner K, Teleanu V, Bullinger L, Nguyen T M, Drognitz K, Moulin J-C, Binnenhei M, Bentz M, Döhner H, Bunjes D, Kuchenbauer F and Ringhoffer M. Reduced-toxicity conditioning for allogeneic hematopoietic cell transplantation in elderly or comorbid patients with AML using fludarabine, BCNU and melphalan: disease stage at transplant determines outcome. : Bone marrow transplantation. 20190308.